382 related articles for article (PubMed ID: 16979183)
21. Structural basis of the drug-binding specificity of human serum albumin.
Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
[TBL] [Abstract][Full Text] [Related]
22. Dioxygenation of human serum albumin having a prosthetic heme group in a tailor-made heme pocket.
Komatsu T; Ohmichi N; Zunszain PA; Curry S; Tsuchida E
J Am Chem Soc; 2004 Nov; 126(44):14304-5. PubMed ID: 15521720
[TBL] [Abstract][Full Text] [Related]
23. A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography.
Zhu L; Yang F; Chen L; Meehan EJ; Huang M
J Struct Biol; 2008 Apr; 162(1):40-9. PubMed ID: 18258455
[TBL] [Abstract][Full Text] [Related]
24. Fatty acid binding sites of human and bovine albumins: differences observed by spin probe ESR.
Muravsky V; Gurachevskaya T; Berezenko S; Schnurr K; Gurachevsky A
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Sep; 74(1):42-7. PubMed ID: 19540798
[TBL] [Abstract][Full Text] [Related]
25. A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.
Buttar D; Colclough N; Gerhardt S; MacFaul PA; Phillips SD; Plowright A; Whittamore P; Tam K; Maskos K; Steinbacher S; Steuber H
Bioorg Med Chem; 2010 Nov; 18(21):7486-96. PubMed ID: 20869876
[TBL] [Abstract][Full Text] [Related]
26. Detergent binding as a sensor of hydrophobicity and polar interactions in the binding cavities of proteins.
Peyre V; Lair V; André V; le Maire G; Kragh-Hansen U; le Maire M; Møller JV
Langmuir; 2005 Sep; 21(19):8865-75. PubMed ID: 16142972
[TBL] [Abstract][Full Text] [Related]
27. Changes of serum albumin affinity for aspirin induced by fatty acid.
Bojko B; Sułkowska A; Maciazek M; Równicka J; Njau F; Sułkowski WW
Int J Biol Macromol; 2008 May; 42(4):314-23. PubMed ID: 18346781
[TBL] [Abstract][Full Text] [Related]
28. Alterations of furosemide binding to serum albumin induced by increased level of fatty acid.
Bojko B; Sułkowska A; Maciazek-Jurczyk M; Równicka J; Pentak D; Sułkowski WW
J Pharm Biomed Anal; 2010 Jan; 51(1):273-7. PubMed ID: 19709838
[TBL] [Abstract][Full Text] [Related]
29. Comparative studies of unfolding and binding of ligands to human serum albumin in the presence of fatty acid: spectroscopic approach.
Varshney A; Ahmad B; Khan RH
Int J Biol Macromol; 2008 Jun; 42(5):483-90. PubMed ID: 18452986
[TBL] [Abstract][Full Text] [Related]
30. Subdomain IIIA of dog albumin contains a binding site similar to site II of human albumin.
Kaneko K; Fukuda H; Chuang VT; Yamasaki K; Kawahara K; Nakayama H; Suenaga A; Maruyama T; Otagiri M
Drug Metab Dispos; 2008 Jan; 36(1):81-6. PubMed ID: 17925384
[TBL] [Abstract][Full Text] [Related]
31. Paclitaxel binding to human serum albumin--automated docking studies.
Paal K; Shkarupin A; Beckford L
Bioorg Med Chem; 2007 Feb; 15(3):1323-9. PubMed ID: 17118665
[TBL] [Abstract][Full Text] [Related]
32. Engineering of a femtomolar affinity binding protein to human serum albumin.
Jonsson A; Dogan J; Herne N; Abrahmsén L; Nygren PA
Protein Eng Des Sel; 2008 Aug; 21(8):515-27. PubMed ID: 18499681
[TBL] [Abstract][Full Text] [Related]
33. Stereoselective binding of human serum albumin.
Chuang VT; Otagiri M
Chirality; 2006 Feb; 18(3):159-66. PubMed ID: 16432913
[TBL] [Abstract][Full Text] [Related]
34. Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations.
Kragh-Hansen U; Brennan SO; Galliano M; Sugita O
Mol Pharmacol; 1990 Feb; 37(2):238-42. PubMed ID: 2304452
[TBL] [Abstract][Full Text] [Related]
35. Development of a fluorescence model for the binding of medium- to long-chain perfluoroalkyl acids to human serum albumin through a mechanistic evaluation of spectroscopic evidence.
Hebert PC; MacManus-Spencer LA
Anal Chem; 2010 Aug; 82(15):6463-71. PubMed ID: 20590160
[TBL] [Abstract][Full Text] [Related]
36. Arginine 485 of human serum albumin interacts with the benzophenone moiety of ketoprofen in the binding pocket of subdomain III A and III B.
Kaneko K; Chuang VT; Ito T; Suenaga A; Watanabe H; Maruyama T; Otagiri M
Pharmazie; 2012 May; 67(5):414-8. PubMed ID: 22764574
[TBL] [Abstract][Full Text] [Related]
37. Surface-enhanced Raman spectroscopy study of the interaction of the antitumoral drug emodin with human serum albumin.
Fabriciova G; Sanchez-Cortes S; Garcia-Ramos JV; Miskovsky P
Biopolymers; 2004 May-Jun 5; 74(1-2):125-30. PubMed ID: 15137109
[TBL] [Abstract][Full Text] [Related]
38. Interaction of c(60)-fullerene and carboxyfullerene with proteins: docking and binding site alignment.
Benyamini H; Shulman-Peleg A; Wolfson HJ; Belgorodsky B; Fadeev L; Gozin M
Bioconjug Chem; 2006; 17(2):378-86. PubMed ID: 16536469
[TBL] [Abstract][Full Text] [Related]
39. Allosteric and binding properties of Asp1-Glu382 truncated recombinant human serum albumin--an optical and NMR spectroscopic investigation.
Fanali G; Pariani G; Ascenzi P; Fasano M
FEBS J; 2009 Apr; 276(8):2241-50. PubMed ID: 19298387
[TBL] [Abstract][Full Text] [Related]
40. O2 and CO binding properties of artificial hemoproteins formed by complexing iron protoporphyrin IX with human serum albumin mutants.
Komatsu T; Ohmichi N; Nakagawa A; Zunszain PA; Curry S; Tsuchida E
J Am Chem Soc; 2005 Nov; 127(45):15933-42. PubMed ID: 16277537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
